Keywords: altana, income, rises, first-quarter, german, drugmaker, saw
Altana's income rises 28% in first-quarter 2006
Article | 08 May 2006
German drugmaker Altana saw consolidated sales grow 28% to 948.0 million euros ($1.19 billion) in the first quarter of 2006, as net income jumped 28% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
